MP72-19 PHASE II STUDY OF AXITINIB FOR DOWNSTAGING CT2A TO CT1 RENAL TUMORS FOR ALLOWING PARTIAL NEPHRECTOMY (AXIPAN)
Author(s) -
C. Lebâcle,
JeanChristophe Bernhard,
Karim Bensalah,
Hervé Baumert,
Hervé Lang,
Didier Jacqmin,
Brigitte Duclos,
Alain Ravaud,
Brigitte Laguerre,
Laurence Albigès,
Armelle Arnoux,
Bernard Escudier,
Jean Jacques Patard
Publication year - 2017
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2017.02.2255
Subject(s) - nephrectomy , axitinib , medicine , urology , cancer , kidney , sunitinib
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom